HAVCR2 and acute myeloid leukemia: We assessed the expression of the activation/inhibitory molecules PD-1, CTLA-4, and TIM-3 on the cell surface of CD8+ T cells and antigen-specific substets of the AML patients after allo-HSCT and healthy controls.